How to Increase Basaglar (Insulin Glargine) Dose
Increase Basaglar by 2 units every 3 days if fasting glucose is 140–179 mg/dL, or by 4 units every 3 days if fasting glucose is ≥180 mg/dL, targeting a fasting range of 80–130 mg/dL. 1
Standard Titration Protocol
Dose Adjustment Based on Fasting Glucose
- Fasting glucose 140–179 mg/dL: Increase by 2 units every 3 days 1, 2
- Fasting glucose ≥180 mg/dL: Increase by 4 units every 3 days 1, 2
- Target fasting glucose: 80–130 mg/dL 1, 2, 3
- If hypoglycemia occurs (glucose <70 mg/dL): Immediately reduce dose by 10–20% 1, 2
Monitoring Requirements
- Check fasting glucose daily during titration to guide adjustments 1, 2
- Continue dose increases every 3 days until fasting glucose consistently reaches target 1, 2
- Reassess every 3–6 months once stable to review HbA1c and overall control 1, 2
Critical Threshold: When to STOP Increasing Basal Insulin
When Basaglar reaches approximately 0.5 units/kg/day (or approaches 1.0 units/kg/day) without achieving glycemic targets, STOP further basal increases and add prandial (mealtime) insulin instead. 1, 2, 4
Signs of "Over-Basalization" (Stop Increasing Basal)
- Basal dose >0.5 units/kg/day without meeting HbA1c goal 1, 2
- Bedtime-to-morning glucose drop ≥50 mg/dL 1, 2
- Recurrent hypoglycemia despite overall hyperglycemia 1, 2
- High day-to-day glucose variability 1, 2
What to Do Instead
- Add 4 units of rapid-acting insulin (lispro, aspart, or glulisine) before the largest meal 1, 2
- Alternatively, start with 10% of current basal dose as prandial insulin 1, 2
- Titrate prandial insulin by 1–2 units every 3 days based on 2-hour post-meal glucose 1, 2
Special Situations Requiring Higher Starting Doses
Severe Hyperglycemia (HbA1c ≥9% or glucose ≥300 mg/dL)
- Start Basaglar at 0.3–0.4 units/kg/day rather than the standard 10 units 1, 2
- Consider immediate basal-bolus therapy (50% basal, 50% prandial) for HbA1c ≥10% with symptoms 1
High-Risk Patients (Elderly, Renal Impairment, Poor Oral Intake)
- Start with lower doses of 0.1–0.25 units/kg/day to minimize hypoglycemia risk 1
- Titrate more conservatively (smaller increments, longer intervals) 1
Patient Self-Titration Instructions
Patients can safely adjust their own Basaglar dose using this algorithm:
- Measure fasting glucose every morning and record values 1, 2
- Every 3 days, calculate average fasting glucose from past 3 days 1, 2
- If average is 140–179 mg/dL: Add 2 units to current dose 1, 2
- If average is ≥180 mg/dL: Add 4 units to current dose 1, 2
- If any reading <80 mg/dL: Decrease by 2 units 1
- If any reading <70 mg/dL: Decrease by 10–20% and contact provider 1, 2
Common Pitfalls to Avoid
- Do NOT continue increasing Basaglar beyond 0.5–1.0 units/kg/day without addressing post-meal hyperglycemia—this causes over-basalization with increased hypoglycemia risk and poor control 1, 2, 4
- Do NOT discontinue metformin when increasing insulin unless contraindicated—metformin reduces insulin requirements by 20–30% and improves outcomes 1
- Do NOT use sliding-scale insulin as monotherapy while titrating basal insulin—this reactive approach is condemned by major guidelines 1
- Do NOT wait longer than 3 days between adjustments in stable patients—this unnecessarily delays achieving glycemic targets 1
Administration Considerations
- Administer Basaglar once daily at the same time each day (morning, evening, or bedtime—patient's choice, but must be consistent) 2, 3
- Inject subcutaneously into abdomen, thigh, or deltoid, rotating sites within the same region 3
- Do NOT mix or dilute Basaglar with any other insulin or solution 3
- In select cases (type 1 diabetes with high variability), may split total daily dose into two equal injections 12 hours apart 2